Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

1.

Building successful relationships in the PLCO Cancer Screening Trial.

Marcus PM, Broski KG, Buys SS, Childs J, Church TR, Gohagan JK, Gren LH, Higgins D, Jaggi R, Jenkins V, Johnson CC, Lappe K, O'Brien B, Ogden SL, Prorok PC, Reding D, Shambaugh V, Yokochi LA, Yurgalevitch S.

Rev Recent Clin Trials. 2015 Jul 31. [Epub ahead of print]

PMID:
26238208
2.

Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial.

Latifa B, Lois E L, Julie V, L SV, E CJ, R RL, Marcus PM.

Rev Recent Clin Trials. 2015 Jul 31. [Epub ahead of print]

PMID:
26238207
3.

Validation of self-report of chest x-ray exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial center.

Gren LH, Lamerato LE, Wright P, Marcus PM.

Rev Recent Clin Trials. 2015 Jul 31. [Epub ahead of print]

PMID:
26238206
4.

Data Processing and Analytic Support in the PLCO Cancer Screening Trial.

Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC.

Rev Recent Clin Trials. 2015 Jul 30. [Epub ahead of print]

PMID:
26238116
5.

Targeted Cancer Screening in Average-Risk Individuals.

Marcus PM, Freedman AN, Khoury MJ.

Am J Prev Med. 2015 Jul 9. pii: S0749-3797(15)00214-7. doi: 10.1016/j.amepre.2015.04.030. [Epub ahead of print]

PMID:
26165196
6.

Lung cancer screening with low dose computed tomography (LDCT): looking back and moving forward.

Marcus PM.

Ann Transl Med. 2015 May;3(Suppl 1):S41. doi: 10.3978/j.issn.2305-5839.2015.03.36. No abstract available.

7.

Cancer screening and diagnosis: opportunities for smoking cessation intervention.

Land SR, Marcus PM.

J Clin Oncol. 2015 May 20;33(15):1631-2. doi: 10.1200/JCO.2015.61.2077. Epub 2015 Apr 20. No abstract available.

PMID:
25897157
8.

Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial.

Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Hickey T, Riley T, Church TR, Weissfeld J, Schoen RE, Marcus PM, Prorok PC.

J Gen Intern Med. 2015 Apr 3. [Epub ahead of print]

PMID:
25835747
9.

Conceptualizing overdiagnosis in cancer screening.

Marcus PM, Prorok PC, Miller AB, DeVoto EJ, Kramer BS.

J Natl Cancer Inst. 2015 Feb 6;107(4). pii: djv014. doi: 10.1093/jnci/djv014. Print 2015 Apr.

PMID:
25663695
10.

Interval lung cancers not detected on screening chest X-rays: How are they different?

Kvale PA, Johnson CC, Tammem├Ągi M, Marcus PM, Zylak CJ, Spizarny DL, Hocking W, Oken M, Commins J, Ragard L, Hu P, Berg C, Prorok P.

Lung Cancer. 2014 Oct;86(1):41-6. doi: 10.1016/j.lungcan.2014.07.013. Epub 2014 Jul 24.

PMID:
25123333
11.

Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Marcus PM, Ogden SL, Gren LH, Childs JC, Pretzel SM, Lamerato LE, Walsh K, Rozjabek HM, Mabie J, Thomas B, Riley T.

Prev Med. 2014 Oct;67:82-8. doi: 10.1016/j.ypmed.2014.07.013. Epub 2014 Jul 16.

PMID:
25038532
12.

Estimating overdiagnosis in lung cancer screening.

Marcus PM.

JAMA Intern Med. 2014 Jul;174(7):1198. doi: 10.1001/jamainternmed.2014.1546. No abstract available.

PMID:
25003884
13.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team.

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

14.

Culturally sensitive approaches to recruitment and retention of Hispanics in the national lung screening trial.

Tenorio SL, O'Donnell CI, Hernandez J, Rozjabek HM, Lynch D, Marcus PM.

J Immigr Minor Health. 2014 Aug;16(4):761-4. doi: 10.1007/s10903-013-9862-0.

PMID:
23780349
15.

Results of initial low-dose computed tomographic screening for lung cancer.

National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S.

N Engl J Med. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120.

16.

Factors associated with the risk of adenoma recurrence in distal and proximal colon.

Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Cross AJ.

Digestion. 2013;87(3):141-6. doi: 10.1159/000346281. Epub 2013 Mar 15.

17.

Obesity, weight change, and risk of adenoma recurrence: a prospective trial.

Laiyemo AO, Doubeni C, Badurdeen DS, Murphy G, Marcus PM, Schoen RE, Lanza E, Smoot DT, Cross AJ.

Endoscopy. 2012 Sep;44(9):813-8. doi: 10.1055/s-0032-1309837. Epub 2012 Aug 27.

18.

Recruitment methods employed in the National Lung Screening Trial.

Marcus PM, Lenz S, Sammons D, Black W, Garg K.

J Med Screen. 2012 Jun;19(2):94-102. doi: 10.1258/jms.2012.012016. Epub 2012 May 31.

19.

Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.

Doria-Rose VP, White MC, Klabunde CN, Nadel MR, Richards TB, McNeel TS, Rodriguez JL, Marcus PM.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1049-59. doi: 10.1158/1055-9965.EPI-12-0343. Epub 2012 May 9.

20.

Tracking and tracing of participants in two large cancer screening trials.

Marcus PM, Childs J, Gahagan B, Gren LH.

Contemp Clin Trials. 2012 Jul;33(4):601-5. doi: 10.1016/j.cct.2012.04.006. Epub 2012 Apr 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk